The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
inhaled drugs for asthma and COPD | Download Table
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis | BMC Pulmonary Medicine | Full Text
Pulmonary and cardiac drugs: clinically relevant interactions | SpringerLink
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
Pharmacological actions of muscarinic antagonists
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Bronchodilators: Beta 2-agonists and muscarinic antagonists | Osmosis
Muscarinic Antagonists - AlphaNet
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Introduction - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
New developments in inhaled therapy | Practice Nursing